Cann Group Limited

CAN

AU000000CAN2

Healthcare Facilities & Services

Market Closed - Australian S.E. Other stock markets 12:10:47 2024-02-29 am EST			5-day change	1st Jan Change
0.062 ^AUD	-1.59%		-.--%	-36.08%

May. 07	Cann Group Secures AU$5 Million Debt Facility	MT
Mar. 22	Cann Group Secures Final Payment for Sale of Southern Facility	MT

Cann Group Limited Appoints Julian John Chick as Director

October 25, 2022

Cann Group Limited appointed Julian John Chick as Director effective from October 26, 2022.

Latest news about Cann Group Limited

Cann Group Secures AU$5 Million Debt Facility	May. 06	MT
Cann Group Secures Final Payment for Sale of Southern Facility	Mar. 21	MT
Cann Group CEO Resigns	Mar. 20	MT
Jenni Pilcher to Become Executive Director of Cann Group Limited	Mar. 20	CI
Cann Group Limited Announces the Resignation of Peter Koetsier as Chief Executive Officer	Mar. 20	CI
Cann Group Executes AU$1.7 Million Sale and Purchase Agreement, Extends Funding Facility	Mar. 17	MT
Cann Group Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 29	CI
Cann Group to Defend Business Against Rua Bioscience Claims As Dispute Goes Legal	Feb. 16	MT
Rua Initiates Legal Action Against Cannoperations	Feb. 15	MT
Atlas Pearls CFO Resigns; Shares Rise 3%	Feb. 08	MT
Cann Group Appoints New Chief Financial Officer	Jan. 07	MT
Cann Group Limited Announces Chief Financial Officer Changes, Commencing on 8 April 2024	Jan. 07	CI
Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs	Jan. 07	CI
Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023	Dec. 03	CI
Cann Group Limited Announces Change of Company Secretary	Dec. 03	CI
Rua Bioscience Announces Changes to the Supply Agreement with Cann Group	Dec. 03	CI
Cann Group Raises AU$2 Million From Obsidian	Nov. 22	MT
How Huawei plans to rival Nvidia in the AI chip business	Nov. 07	RE
Heritage Cannabis Begins Recreational Products Sales in New York	23-10-23	MT
US chip curbs give Huawei a chance to fill the Nvidia void in China	23-10-20	RE
Cann Group to Supply Additional Cannabis Flower, Oil Products to Levin	23-09-20	MT
Cann Group Limited Signs Variation Agreement with Key Customer for Additional Supply of Cannabis Flower Products to 31 December 2023	23-09-20	CI
Cann Global Seeks Further Trading Suspension	23-09-18	MT
Transcript : Cann Group Limited, 2023 Earnings Call, Aug 28, 2023	23-08-27
Cann Group Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-27	CI

Cann Group Limited is an Australia-based company that is focused on developing, producing, and supplying innovative cannabis medicines. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The Company supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. It also owns Satipharm and its patent-protected capsule technology. The Company's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

Sector

Healthcare Facilities & Services

Calendar

2024-08-25 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Medical Farming

	1st Jan change	Capi.
CANN GROUP LIMITED	-36.08%	17.97M
CRUCIAL INNOVATIONS CORP.	-.--%	339M
ASCEND WELLNESS HOLDINGS, INC.	+32.99%	289M
AYR WELLNESS INC.	+47.33%	280M
ORGANIGRAM HOLDINGS INC.	+51.74%	188M
INTERCURE LTD.	+144.22%	146M
JUSHI HOLDINGS INC.	+53.54%	136M
THE CANNABIST COMPANY HOLDINGS INC.	-39.55%	129M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
4FRONT VENTURES CORP.	+19.23%	97.22M

Medical Farming